217 related articles for article (PubMed ID: 10225750)
1. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia.
Koga N
Ther Apher; 1997 Aug; 1(3):260-70. PubMed ID: 10225750
[TBL] [Abstract][Full Text] [Related]
2. Angiographic and pathological studies on regression of coronary atherosclerosis of FH patients who received LDL-apheresis treatment.
Koga N; Iwata Y; Yamamoto A
Artif Organs; 1992 Apr; 16(2):171-6. PubMed ID: 10078240
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients.
Koga N; Watanabe K; Kurashige Y; Sato T; Hiroki T
J Intern Med; 1999 Jul; 246(1):35-43. PubMed ID: 10447223
[TBL] [Abstract][Full Text] [Related]
4. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia.
Koga N; Iwata Y
Atherosclerosis; 1991 Sep; 90(1):9-21. PubMed ID: 1799400
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Olbricht CJ; Schoeppe E
Ther Apher; 1997 Aug; 1(3):242-8. PubMed ID: 10225746
[TBL] [Abstract][Full Text] [Related]
6. LDL-apheresis and improvement in the coronary atherosclerosis of familial hypercholesterolemia--correlation of computerized quantitative coronary angiography with autopsy findings.
Koga N; Satoh T; Watanabe K; Kohchi K; Iwata Y; Minami H
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):37-52. PubMed ID: 1751679
[TBL] [Abstract][Full Text] [Related]
7. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).
Matsuzaki M; Hiramori K; Imaizumi T; Kitabatake A; Hishida H; Nomura M; Fujii T; Sakuma I; Fukami K; Honda T; Ogawa H; Yamagishi M
J Am Coll Cardiol; 2002 Jul; 40(2):220-7. PubMed ID: 12106923
[TBL] [Abstract][Full Text] [Related]
8. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
[TBL] [Abstract][Full Text] [Related]
10. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators.
Tatami R; Inoue N; Itoh H; Kishino B; Koga N; Nakashima Y; Nishide T; Okamura K; Saito Y; Teramoto T
Atherosclerosis; 1992 Jul; 95(1):1-13. PubMed ID: 1642687
[TBL] [Abstract][Full Text] [Related]
11. Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.
Masaki N; Tatami R; Kumamoto T; Izawa A; Shimada Y; Takamatsu T; Katsushika S; Ishise S; Maruyama Y; Yoshimoto N
Int Heart J; 2005 Sep; 46(5):833-43. PubMed ID: 16272774
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
Richter WO; Donner MG; Höfling B; Schwandt P
Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
[TBL] [Abstract][Full Text] [Related]
13. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
[TBL] [Abstract][Full Text] [Related]
14. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R
Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162
[TBL] [Abstract][Full Text] [Related]
15. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
[TBL] [Abstract][Full Text] [Related]
16. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
17. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
[TBL] [Abstract][Full Text] [Related]
19. Clinical application and effectiveness of low-density lipoprotein apheresis in the treatment of coronary artery disease.
Daida H; Yamaguchi H
Ther Apher; 1997 Aug; 1(3):253-4. PubMed ID: 10225748
[TBL] [Abstract][Full Text] [Related]
20. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
